Literature DB >> 19132189

Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.

Subramanian Yegneswaran1, Phuong M Nguyen, Andrew J Gale, John H Griffin.   

Abstract

The hypothesis that prothrombin (FII) protects coagulation factor Va (FVa) from proteolytic inactivation by activated protein C (APC) was tested using purified proteins. FII dose-dependently protected FVa from APC proteolysis under conditions where competition of proteins for binding to negatively-charged phospholipid surface was not relevant (i.e. either at high phospholipid vesicle concentrations or using soluble dicaproylphosphatidylserine at levels below its critical micellar concentration). Cleavages in FVa at both Arg(506) and Arg(306) by APC were inhibited by FII. FII did not alter the amidolytic activity of APC towards chromogenic oligopeptide substrates or inhibit FVIIIa inactivation by APC, implying that the FII-mediated protection of FVa from APC proteolysis was due to the ability of FII to inhibit protein-protein interactions between FVa and APC. FII also protected FVa from inactivation by Gla-domainless APC, ruling out a role for the APC Gla domain for these observations. To identify domains of FII responsible for the observed phenomenon, various forms or fragments of FII were employed. Biotin-Phe-ProArg-CMK-inhibited meizothrombin and fII-fragment 1*2 protected FVa from proteolysis by APC. In contrast, no significant protection of FVa from APC cleavage was observed for Gladomainless-FII, prethrombin-1, prethrombin-2, FII fragment 1 or active site inhibited-thrombin (DEGR-thrombin). Overall, these data demonstrate that the Gla domain of FII linked to kringle 1 and 2 is necessary for the ability of FII to protect FVa from APC cleavage and support the general concept that assembly of the FII activation complex (FXa*FVa*FII*lipid surface) protects FVa from APC inactivation so that the procoagulant, thrombin generating pathway can act unhindered by APC. Only following FII activation and dissociation of the FII Gla domain fragments from the FII-ase complex, can APC inactivate FVa and down-regulate thrombin generation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19132189      PMCID: PMC2730196          DOI: 10.1160/th08-07-0491

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  Inactivation of human coagulation factor V by activated protein C.

Authors:  K Suzuki; J Stenflo; B Dahlbäck; B Teodorsson
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

Review 2.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

3.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

Authors:  M E Nesheim; J B Taswell; K G Mann
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

4.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

5.  Proexosite-1 on prothrombin is a factor Va-dependent recognition site for the prothrombinase complex.

Authors:  Lin Chen; Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2003-05-14       Impact factor: 5.157

6.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

7.  The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction.

Authors:  S Krishnaswamy; K G Mann; M E Nesheim
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

8.  Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.

Authors:  J Rosing; R F Zwaal; G Tans
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

9.  Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

Authors:  M E Nesheim; W M Canfield; W Kisiel; K G Mann
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

10.  Active site-independent recognition of substrates and product by bovine prothrombinase: a fluorescence resonance energy transfer study.

Authors:  Danilo S Boskovic; Thomas Troxler; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

View more
  4 in total

1.  Inhibition of thrombin formation by active site mutated (S360A) activated protein C.

Authors:  Gerry A F Nicolaes; Paul E Bock; Kenneth Segers; Karin C A A Wildhagen; Björn Dahlbäck; Jan Rosing
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

2.  Down regulation of prothrombinase by activated protein C during prothrombin activation.

Authors:  Paul Y Kim; Michael E Nesheim
Journal:  Thromb Haemost       Date:  2010-04-13       Impact factor: 5.249

3.  A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation.

Authors:  An-Chun Cheng; Hua-Lin Wu; Guey-Yueh Shi; Inn-Ho Tsai
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

4.  Modeling of human factor Va inactivation by activated protein C.

Authors:  Maria Cristina Bravo; Thomas Orfeo; Kenneth G Mann; Stephen J Everse
Journal:  BMC Syst Biol       Date:  2012-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.